Ying Wang

Ying Wang

Auto-generated profile, based on publicly available information

Ying Wang

Department of Cardiovascular Medicine, Shanghai Institute of Hypertension, National Center for Translational Medicine · Shanghai, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2020 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
YCYi Chen
Yi Chen
QHQi-Fang Huang
Qi-Fang Huang
CSChang-Sheng Sheng
Chang-Sheng Sheng
WZWei Zhang
Wei Zhang
SSShuai Shao
Shuai Shao
JWJi-Guang Wang
Ji-Guang Wang
Atrial fibrillation (AF) is underdiagnosed and especially undertreated in China. We aimed to investigate the prevalence of unknown and untreated AF in community residents (≥65 years old) and to determine whether an education intervention could improve oral anticoagulant (OAC) prescription. We performed a single–time point screening for AF with a handheld single-lead electrocardiography (ECG) in Chinese residents (≥65 years old) in 5 community health centers in Shanghai from April to September 2017. Disease education and advice on referral to specialist clinics for OAC treatment were provided to all patients with actionable AF (newly detected or undertreated known AF) at the time of screening, and education was reinforced at 1 month. Follow-up occurred at 12 months. In total, 4,531 participants were screened (response rate 94.7%, mean age 71.6 ± 6.3 years, 44% male). Overall AF prevalence was 4.0% (known AF 3.5% [n = 161], new AF 0.5% [n = 22]). The 183 patients with AF were older (p < 0.001), taller (p = 0.02), and more likely to be male (p = 0.01), and they had a higher prevalence of cardiovascular disease than those without AF (p < 0.001). In total, 85% (155/183) of patients were recommended for OAC treatment by the established guidelines (CHA2DS2-VASc ≥ 2 for men; ≥ 3 for women). OAC prescription rate for known AF was 20% (28/138), and actionable AF constituted 2.8% of all those screened. At the 12-month follow-up in 103 patients (81% complete), despite disease education and advice on specialist referral, only 17 attended specialist clinics, and 4 were prescribed OAC. Of those not attending specialist clinics, 71 chose instead to attend community health centers or secondary hospital clinics, with none prescribed OAC, and 15 had no review. Of the 17 patients with new AF and a class 1 recommendation for OAC, only 3 attended a specialist clinic, and none were prescribed OAC. Of the 28 AF patients taking OAC at baseline, OAC was no longer taken in 4. Ischemic stroke (n = 2) or death (n = 3) occurred in 5/126 (4%), with none receiving OAC. As screening was performed at a single time point, some paroxysmal AF cases may have been missed; thus, the rate of new AF may be underestimated. We demonstrated a noticeable gap in AF detection and treatment in community-based elderly Chinese: actionable AF constituted a high proportion of those screened. Disease education and advice on specialist referral are insufficient to close the gap. Before more frequent or intensive screening for unknown AF could be recommended in China, greater efforts must be made to increase appropriate OAC therapy in known AF to prevent AF-related stroke.

28 June 2023 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
YCYu Chen
Yu Chen
MLMing‐Xuan Li
Ming‐Xuan Li
YWYing Wang
Ying Wang
XJXian Jin
Xian Jin
LLLiang Liu
Liang Liu
CSCheng-Xing Shen
Cheng-Xing Shen
The clinical significance of central beyond brachial blood pressure (BP) remains unclear. In patients who underwent coronary angiography, the authors explored whether elevated central BP would be associated with coronary arterial disease (CAD) irrespective of the status of brachial hypertension. From March 2021 to April 2022, 335 patients (mean age 64.9 years, 69.9% men) hospitalized for suspected CAD or unstable angina were screened in an ongoing trial. CAD was defined if a coronary stenosis of ≥50%. According to the presence of brachial (non‐invasive cuff systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg) and central (invasive systolic BP ≥130 mmHg) hypertension, patients were cross‐classified as isolated brachial hypertension (n = 23), isolated central hypertension (n = 93), and concordant normotension (n = 100) or hypertension (n = 119). In continuous analyses, both brachial and central systolic BPs were significantly related to CAD with similar standardized odds ratios (OR, 1.47 and 1.45, p < .05). While categorical analyses showed that patients with isolated central hypertension or concordant hypertension had a significantly higher prevalence of CAD and the Gensini score than those with concordant normotension. Multivariate‐adjusted OR (95% confidence interval [CI]) for CAD was 2.24 (1.16 to 4.33, p = .009) for isolated central hypertension and 3.02 (1.58 to 5.78, p < .001) for concordant hypertension relative to concordant normotension. The corresponding OR (95% CI) of a high Gensini score was 2.40 (1.26–4.58) and 2.17 (1.19–3.96), respectively. In conclusion, regardless of the presence of brachial hypertension, elevated central BP was associated with the presence and severity of CAD, indicating that central hypertension is an important risk factor for coronary atherosclerosis.

17 July 2026 in American Journal of Hypertension
Verified
Journal Article
Closed access
YWYing Wang
Ying Wang
YLYan Li
Yan Li
JWJi-Guang Wang
Ji-Guang Wang
Background: Intensive blood pressure (BP) lowering increases acute kidney injury risk, despite cardiovascular benefits. We investigated the association between treatment-induced BP changes and kidney function decline, while accounting for arterial stiffness. Methods: This post-hoc analysis included 266 patients with hypertension from a 20‑week double‑blind trial treated with calcium-channel blockers. Kidney dysfunction was defined as an estimated glomerular filtration rate (eGFR) <60 mL/minute·1.73 m2 or a decrease ≥30% from baseline. Arterial stiffness was measured as brachial-ankle pulse wave velocity (baPWV). Results: At baseline, systolic/diastolic BP (mean ± SD, 153.2 ± 9.3/91.8 ± 9.5 mm Hg) was associated positively (r = 0.20 [95% CI, 0.09 to 0.32]/0.23 [95% CI, 0.11 to 0.34]) with serum creatinine (72.1 ± 16.2 μmol/L), and inversely (r = −0.25 [95% CI, −0.36 to −0.14]/−0.16 [95% CI, −0.28 to −0.04]) with eGFR (91.6 ± 13.8 mL/minute·1.73 m2). The associations with clinic systolic BP were weakened with higher baPWV, being observed in tertiles 1 and 2 (r ≥ 0.30 or ≤−0.27), but not in tertile 3. After 20 weeks of treatment, the incidence of kidney dysfunction was 0%, 4.8%, and 6.4%, respectively, in tertiles 1, 2, and 3 of baPWV (odds ratio for tertile 3 vs tertile 1, 2.23 [95% CI, 0.84-5.95]). In longitudinal analysis, the least squares mean change from baseline in eGFR was −3.7 mL/minute·1.73 m2 (95% CI, −4.3 to 1.1) in patients within tertile 3 of both baseline baPWV and treatment-induced clinic systolic BP changes. Conclusions: In patients with stiffer arteries, kidney function at baseline was not associated with higher BP, and its decline during follow-up was greater when clinic BP was intensively reduced.

1 July 2026 in Hypertension
Verified
Journal Article
Closed access
DADe-Wei An
De-Wei An
YWYing Wang
Ying Wang
YCYi-Bang Cheng
Yi-Bang Cheng
DZDong-Yan Zhang
Dong-Yan Zhang
QHQi-Fang Huang
Qi-Fang Huang
YLYan Li
Yan Li
BACKGROUND: Whether central systolic blood pressure (cSBP) compared with brachial systolic blood pressure (bSBP) improves risk stratification remains debated. This study investigated whether cSBP is more closely associated with total and cardiovascular mortality than bSBP when recorded by 24-hour ambulatory BP monitoring with an arm cuff-based oscillometric monitor. METHODS: Consecutive patients referred for ambulatory BP monitoring and enrolled in the Shanghai Ruijin Ambulatory BP Monitoring Registry (2017–2023) were analyzed. bSBP and cSBP were recorded over 24 hours. cSBP was calibrated on brachial systolic and diastolic BP (cSBPc1) or on mean arterial pressure and brachial diastolic BP (cSBPc2). Total and cardiovascular mortality up to December 31, 2024, was assessed by record linkage with International Classification of Diseases, Tenth Revision , coded death certificates. Linear and nonlinear Cox proportional hazard regression was applied with age as the underlying time-scale and adjusted for established cardiovascular risk factors. RESULTS: Over 4.0 years of follow-up, 505 of 36 594 participants (52.8% women; median age, 53.4 years) died, 174 from cardiovascular disease. With multivariable adjustment applied, the nonlinear compared with linear Cox models provided a better model fit for both end points ( P <0.001), irrespective of the period of the day and the calibration method of cSBP. Adding any 24-hour SBP to the base model increased the C statistics for total and cardiovascular mortality (0.003≤ P ≤0.06). Adding cSBPc1 or cSBPc2 to the base model extended by bSBP also increased the C statistics, but not by a statistically significant amount (0.054≤ P ≤0.22). CONCLUSIONS: cSBP compared with bSBP did not improve the associations with mortality. Measurement of the ambulatory bSBP is adequate for BP-based risk stratification.

6 November 2026 in Pulse
Verified
Journal Article
Open access
MWMei Wang
Mei Wang
YCYi-Bang Cheng
Yi-Bang Cheng
DZDong-Yan Zhang
Dong-Yan Zhang
DADe-Wei An
De-Wei An
MLMing-Xuan Li
Ming-Xuan Li
YLYan Li
Yan Li
Carotid-femoral (cfPWV) and brachial-ankle pulse wave velocity (baPWV) are reliable indicators of arterial stiffness with independent associations with target organ damage (TOD). However, it remains unclear whether the associations of TOD with the two PWVs might differ, especially when comparing TOD between patients with isolated (discordant) or concordant elevation of the two PWVs. Consecutive untreated outpatients referred for 24-hour ambulatory blood pressure monitoring at Ruijin Hospital were recruited. Measures of TOD included pulsatility index of cerebral arteries, carotid intima-media thickness (IMT), estimated glomerular filtration rate (eGFR), and log-transformed urinary albumin-to-creatinine ratio (log-UACR). Among 1798 participants, 1170 (65.1%) had ambulatory hypertension. CfPWV (mean± SD, 7.9 ± 1.3 m/s) and baPWV (14.6 ± 2.2 m/s) were closely intercorrelated (r=0.67, P<0.001). Both cfPWV and baPWV, as continuous variables, were significantly (P<0.001) associated with TOD measures in a similar strength (P≥0.11). In multivariable-adjusted categorical analyses, when the cfPWV/baPWV <9/<16 m/s group was set as the reference, participants with isolated elevations of either cfPWV or baPWV had similarly (P≥0.057) worse TOD measures, and concordant elevations in both PWVs demonstrated the most severe TOD in continuous measures (P<0.001), including increased pulsatility index (90.2 vs 83.2 % for right middle cerebral artery), carotid IMT (648.3 vs 627.9 µm), and log-UACR (-0.10 vs -0.35 mg/mmol), except eGFR (104.0 vs 104.6 mL/min/1.73 m², P=0.22). In conclusion, both cfPWV and baPWV are similarly independently associated with TOD with similar strength. Isolated elevations of either PWV showed comparable TOD, while dual elevations were associated with significant TOD, suggesting that the two PWV measures may capture overlapping yet distinct vascular damage.